ECP
SRPT icon

Elk Creek Partners’s Sarepta Therapeutics SRPT Stock Holding History

Elk Creek Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-55,727
Closed -$4.2M – 109
2019
Q3 		$4.2M Buy
55,727
+6,908
+14% +$816K 0.36% 99
2019
Q2 		$7.42M Sell
48,819
-1,493
-3% -$181K 0.55% 84
2019
Q1 		$6M Buy
50,312
+1,442
+3% +$185K 0.43% 89
2018
Q4 		$5.33M Sell
48,870
-23,148
-32% -$2.89M 0.44% 90
2018
Q3 		$11.6M Sell
72,018
-78,854
-52% -$10.8M 0.63% 69
2018
Q2 		$19.9M Sell
150,872
-174,484
-54% -$16.5M 1.1% 20
2018
Q1 		$24.1M Sell
325,356
-378,068
-54% -$25.2M 1.41% 14
2017
Q4 		$39.1M Sell
703,424
-13,092
-2% -$694K 2.3% 3
2017
Q3 		$32.5M Buy
716,516
+124,647
+21% +$4.98M 2.05% 7
2017
Q2 		$20M Buy
591,869
+29,347
+5% +$956K 1.29% 18
2017
Q1 		$16.7M Buy
562,522
+246,059
+78% +$7.62M 1.02% 32
2016
Q4 		$8.68M Buy
+316,463
New +$12.7M 0.59% 68

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Elk Creek Partners's SRPT Position: Q4 2019 in Review

Elk Creek Partners sold out of Sarepta Therapeutics (SRPT) in Q4 2019, closing a stake of 55,727 shares — an estimated $4.2M sold.

Elk Creek Partners first reported a position in SRPT in Q4 2016 and held it in 12 quarters. The position peaked at $39.1M in Q4 2017. 390 funds tracked by Wall St. Rank hold SRPT as of Q4 2019.

  • Elk Creek Partners reported no remaining Sarepta Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Elk Creek Partners sold 55,727 Sarepta Therapeutics shares in Q4 2019, an estimated $4.2M.
  • Elk Creek Partners first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 12 quarters.
  • Elk Creek Partners's Sarepta Therapeutics position peaked at $39.1M in Q4 2017.
  • 390 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2019.

Based on Elk Creek Partners's 13F filing for Q4 2019, filed 14 Feb 2020.